Topic: artificial intelligence
The startup will use the series A funds to scale its predictive analytics platform while working to form partnerships with healthcare organizations.
The company's Owkin Socrates platform applies transfer and federated learning to clinical research.
Canadian biotech Adapsyn Bioscience has developed a system that could sift out promising drug candidates from microbes more quickly—catching the eye of a big pharma partner.
Datavant will partner its 150 data sets with the three organizations' unique capabilities to drive clinical trial intelligence.
Eric Perakslis' experience with Takeda will help facilitate a new collaboration between the two companies.
The technology is designed to support the performance and interpretation of echocardiograms.
Genomics, bioelectronics and artificial intelligence are clear themes among FierceMedTech's 2017 Fierce 15 companies.